Tdspharm Co., Ltd. (KOSDAQ:464280)
South Korea · Delayed Price · Currency is KRW 5,910.00
+90.00 (1.55%)
Sep 4, 2026, 3:30 PM KST
Tdspharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 32,682 | 54,471 | 73,217 | - | - | - | |
Market Cap Growth | -41.66% | -25.60% | - | - | - | - |
Enterprise Value | 18,815 | 30,721 | 48,283 | - | - | - |
Last Close Price | 5910.00 | 9850.00 | 13240.00 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 6.07 | 12.74 | 19.69 | - | - | - |
PS Ratio | 0.99 | 1.97 | 2.66 | - | - | - |
PB Ratio | 0.73 | 1.27 | 1.90 | - | - | - |
P/TBV Ratio | 0.73 | 1.28 | 1.91 | - | - | - |
P/FCF Ratio | - | - | 22.79 | - | - | - |
P/OCF Ratio | 5.01 | 14.41 | 18.64 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.57 | 1.11 | 1.76 | - | - | - |
EV/EBITDA Ratio | 2.96 | 6.88 | 10.98 | - | - | - |
EV/EBIT Ratio | 3.34 | 8.16 | 12.95 | - | - | - |
EV/FCF Ratio | - | - | 15.03 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.31 | 0.18 | 0.18 | 0.31 | 0.38 | 0.44 |
Debt / EBITDA Ratio | 2.18 | 1.73 | 1.57 | 1.18 | 1.38 | 2.01 |
Debt / FCF Ratio | - | - | 2.15 | 2.32 | 3.00 | 2.05 |
Net Debt / Equity Ratio | -0.31 | -0.29 | -0.62 | -0.35 | -0.16 | -0.06 |
Net Debt / EBITDA Ratio | -2.18 | -2.80 | -5.41 | -1.32 | -0.59 | -0.28 |
Net Debt / FCF Ratio | 2.30 | 1.37 | -7.40 | -2.59 | -1.29 | -0.28 |
Asset Turnover | 0.58 | 0.54 | 0.66 | 0.93 | 0.89 | 0.74 |
Inventory Turnover | 6.74 | 7.00 | 7.02 | 9.51 | 9.49 | 8.63 |
Quick Ratio | 1.77 | 2.40 | 3.46 | 2.18 | 1.59 | 1.16 |
Current Ratio | 2.00 | 2.66 | 3.77 | 2.43 | 1.83 | 1.37 |
Return on Equity (ROE) | 12.18% | 10.52% | 12.10% | 22.73% | 20.06% | 12.70% |
Return on Assets (ROA) | 6.20% | 4.56% | 5.61% | 9.73% | 8.23% | 5.40% |
Return on Invested Capital (ROIC) | 15.60% | 14.38% | 22.18% | 28.30% | 22.29% | 12.65% |
Return on Capital Employed (ROCE) | 12.50% | 8.80% | 9.70% | 21.00% | 18.30% | 13.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 15.77% | 7.85% | 5.08% | - | - | - |
FCF Yield | -18.45% | -16.71% | 4.39% | - | - | - |
Buyback Yield / Dilution | -7.98% | -14.22% | -8.74% | 0.07% | -4511.34% | 7.60% |